Impact of viral oncogenesis on responses to anti-cancer drugs and irradiation

Critical Reviews in Oncogenesis

Volumn 11, Issue 2, 2000, Pages 165-187

  Efferth, T ^a   Grassmann, R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; DNA repair; Drug resistance; Growth arrest; Radioresistance; Viral oncogenes

Indexed keywords

ANTINEOPLASTIC AGENT; VIRUS PROTEIN;

APOPTOSIS; CANCER RADIOTHERAPY; CANCER THERAPY; CELL DEATH; DETOXIFICATION; DNA REPAIR; GENE INACTIVATION; GROWTH DISORDER; HERPES VIRUS; IRRADIATION; MULTIDRUG RESISTANCE; ONCOGENE; PAPOVAVIRUS; PROTEIN PROTEIN INTERACTION; RADIOSENSITIVITY; RETROVIRUS; REVIEW; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS;

ANIMAL; ANTINEOPLASTIC AGENTS; CARCINOMA; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENES, P53; HEPADNAVIRIDAE; HERPESVIRIDAE; HUMAN; LYMPHOMA; NEOPLASMS; P-GLYCOPROTEIN; PAPILLOMAVIRIDAE; POLYOMAVIRIDAE; SIGNAL TRANSDUCTION; TUMOR VIRUS INFECTIONS;

EID: 0033833572     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (177)

1. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53
2. Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein
3. Hepatitis B virus x protein interferes with cellular DNA repair
4. Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function
5. Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism
6. Repression of Bax gene expression by the HTLV-I Tax protein: Implications for suppression of apoptosis in virally infected cells
7. Viral co-factors in liver cancer: Lessons from hepatitis B virus
8. Functional p53 protein in human papillomavirus-positive cancer cells
9. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: Repression of E6/E7-oncogene expression and induction of apoptosis
10. Induction of the p53-target gene GADD45 in HPV-positive cancer cells
11. Growth factor modulation of p53 mediated growth arrest versus apoptosis
12. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats
13. p53 functional impairment and high p21(waf1/eip1) expression in human T-cell lymphotrophic/Leukemia Virus Type I-transformed T cells
14. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells
15. The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinase
16. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product
17. Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: Apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation
18. Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: The possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors
19. The hepatitis B virus x gene induces p53-mediated programmed cell death
20. Tax of the human T-lymphotropic virus type I transactivates promotor of the MDR-1 gene
21. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells
22. P53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts
23. BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation
24. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7
25. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo
26. E1A signaling to p53 involves the p19(ARF) tumor suppressor
27. Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIa, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21(Waf1)
28. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation
29. Transactivation of the human MDR1 gene by hepatitis B virus x gene product
30. Woodchuck p-glycoprotein found in virus-induced hepatocellular carcinomas binds anticancer drugs
31. Overexpression of a P-glycoprotein in hepatocellular carcinomas from woodchuck hepatitis virus-infected woochucks (Marmota monax)
32. Immunocytochemical detection of oncoproteins in animal and human tumor lines with acquired or inherent multidrug resistance
33. Role of oncogenes in resistance and killing by cancer therapeutic agents
34. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: Involvement of TRAF3 as a common mediator
35. Carcinogen-induces mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas
36. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline
37. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard
38. Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment
39. Oxidative stress responses in Escherichia coli and Salmonella typhimurium
40. Oncogene-dependent apoptosis is mediated by caspase-9
41. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
42. Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation
43. The ability of human papilloimavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arest
44. Adenovirus E1a-mediated tumor suppression by a c-erbB-2/neu-independent mechanism
45. High-risk HPV-positive human cancer cell lines show different sensitivity to cisplatin-induced apoptosis correlated with the p21(Waf1/ Cip1) level
46. Evaluation of the mutqgenic effects of SV40 in mouse, hamster, and mouse-human hybrid cells
47. Human immunodeficiency virus I-induced expression of P-glycoprotein
48. Sensitivity to ionizing radiation of transformed human cells containing mutant ras genes
49. Downregulation of DNA excision repair by the hepatitis B virus-x protein occurs in p53-proficient and p53-deficient cells
50. DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6
51. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells
52. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: Modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diaceto)(dichloro)-platinum(IV)
53. pRB plays an essential role in cell cycle arrest induced by DNA damage
54. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
55. P53 inactivation by HPV16 E6 results in increased mutagenesis in human cells
56. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
57. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation
58. Perturbation of the p53 response by human papillomavirus type 16 E7
59. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro
60. Enhanced sensitivity of small cell lung cancer cell lines to cisplatin and etoposide after infection with adeno-associated virus type 2
61. Adverse effect of radiotherapy on adjuvant chemotherapy of the breast
62. Abrogation of p53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation
63. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death
64. Epstein-Barr virus BHRF1 prohibits the cells of nasopharyngeal carcinoma from apoptosis
65. The effect of Epstein-Barr virus gene BHRF1 expression on radioresistance of nasopharyngeal carcinoma cells
66. Flow cytometric analysis of BHRF1 expression prohibiting apoptosis induced by radiation
67. P53-dependent growth arrest of REF52 cells containing newly amplified DNA
68. Cell and tisue responses to oxidative damage
69. HTLV-1 trans-activator protein, Tax, is a transrepressor of the human β-polymerase gene
70. Hepatitis B virus X protein inhibits nucleotide excision repair
71. Radio-resistant DNA synthesis in SV40-immortalized ataxia telangiectasia fibroblasts
72. Modification of the radiosensitivity of human testicular cancer cells by simian virus 40 sequences
73. Disruption of nucleotide excision repair by the human T-cell leukemia virus type Tax protein
74. Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracil
75. Inactivation of G2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6
76. Carcinogenesis and the response of tumours to anticancer drugs
77. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage
78. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates
79. Tissue-specific expression and activation of N-methylpurine-DNA-glycosylase in thymic carcinomas of transgenic mice expressing the SV40 large T-antigen
80. The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses
81. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1 a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice
82. Viability of wild type p53-containing and p53-deficient tumor cells following anticancer treatment: The use of human papillomavirus E6 to target p53
83. Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: Correlation with patient response to therapy
84. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein
85. Transcriptional activation of the mouse mdr3 gene coincides with the appearance of novel transcription initiation sites in multidrug-resistant P388 tumor cells
86. Activation of the mouse mdr3 gene by insertion of retroviruses in multi-drug-resistant P388 tumor cells
87. Effect of simian virus large T antigen expression on cell cycle control and apoptosis in rat pleural mesothelial cells exposed to DNA damaging agents
88. Role of viral infections in the induction of adverse drug reaction
89. Diminished capacity for p53 in ediating a radiation-induced G1 arrest in established human tumor cell lines
90. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents
91. Retroviral insertion mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatium(II) resistance
92. Alterations in oncogene expression and radiosensitivity in the most frequently used SV40-transformed human skin fibroblasts
93. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins
94. α-Bromoacryloyl derivative of distamycin A (PNU 15 1807): A new non-covalent minor groove DNA binder with antineoplastic activity
95. Use of host cell reactivation of cisplatin-treated adenovirus 5 in human cell lines to detect repair of drug-treated DNA
96. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53
97. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
98. Persistent DNA damage induced by ultraviolet light inhibits p21 waf1 and bax expression: Implications for DNA repair, UV sensitivity and the induction of apoptosis
99. Synergistic effect of the v-myc oncogene with H-ras on radioresistance
100. Anti-apoptotic strategies of lymphotropic viruses
101. Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines
102. Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*)
103. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain
104. Effects of antimetabolites on adenovirus replication in sensitive and resistant human melanoma cell lines
105. Apoptin specifically causes apoptosis in tumor cells and after UV-treatment in untransformed cells from cancer-prone individuals: A review
106. Viruses and apoptosis
107. Lack of correlation of MRP and γ-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells
108. Combination therapy with podophyllin and vidarabine for human papillomavirus positive cervical intraepithelial neoplasia
109. High susceptibility of an Epstein-Barr virus-converted Burkitt's lymphoma cell line to cytotoxic drugs
110. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells
111. Multiple fractions of γ rays induced resistance to cis-dichloro-diammineplatinum(II) and methotrexate in human HeLa cells
112. High frequency variation in mammary tumor virus expression in cell culture
113. pSV3neo transfection and radiosensitivity of human cancer cell lines
114. Effects of adriamycin and etoposide on the replication of adenovirus 5 in sensitive and resistant human tumour cells
115. Relationship between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase iso-enzymes and adenovirus replication in human tumour cell lines
116. Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification
117. Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: Role of tax gene
118. Oncogene-transformed NIH 3T3 cells display radiation resistance levels indicative of a signal transduction pathway leading to the radiation-resistant phenotype
119. Phosphorylation of p53: A novel pathway for p53 inactivation in human T- cell lymphotropic virus type 1-transformed cells
120. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen
121. P53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus
122. Defective repair of UV-damaged DNA in human tumor and SV40-transformed human cells but not in adenovirus-transformed human cells
123. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells
124. Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines
125. Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells
126. 2): A possible effector of eukaryontic gene expression
127. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins
128. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants
129. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene
130. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma
131. Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts
132. The effect of functional inactivation of TP53 by HPV-E6 transformation on the induction of chromosome aberrations by gamma rays in human tumor cells
133. Functional inactivation of p53 by HPV-E6 transformation is associated with a reduced expression of radiation-induced potentially lethal damage
134. Apoptosis. Biochemical events and relevance to cancer chemotherapy
135. Antiviral agents as adjuncts in cancer chemotherapy
136. Inhibition of nuclear factor-κB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis
137. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes
138. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation
139. Involvement of the p53 tumor suppressor in repair of u.v. type DNA repair
140. Human papilloma-virus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways
141. Expression of growth-related and drug-resistance genes in HTLV-I-positive and HTLV-I-negative post-thymic T-cell malignancies
142. Use of transgenic mice reveals cell-specific transformation by a simian virus 40 T-antigen amino-terminal muant
143. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320)
144. Establishment of persistent infection with HIV-1 abrogates the caspase-3 dependent apoptotic signaling pathway in U937 cells
145. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection
146. Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas
147. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation
148. Identification of human papillomavirus types 16 and 18 deoxyribonucleic acid sequences in bulky cervical cancer after chemotherapy
149. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A
150. Human T-cell leukemia virus type I. Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors
151. Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer
152. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis
153. Overexpression of P-glycoproptein in rat hepatocellular carcinomas induced with N-nitrosomorpholine
154. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-π, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas
155. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53
156. Viruses and human cancer
157. Adeno-associated virus sensitizes HeLa cell tumors to γ rays
158. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
159. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids
160. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins
161. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2
162. The human papilloma virus 16 E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage
163. Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced methotrexate and adriamycin resistance in CHO cells by adeno-associated virus type 2
164. Modification of the radiosensitivity of human cells to which simian virus 40 T-antigen was transfected
165. Retroviral expression of a mutant (Gly-533) human DNA topoisomerase I cDNA confers a dominant form of camptothecin resistance
166. Methotrexate resistance in human uroepithelial cells with p53 alterations
167. Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells
168. P53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines
169. Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cells
170. Human immunodeficiency virus type 1 induces 1-β-D-arabinofuranosylcytosine resistance in human H9 cell line
171. Induction of resistance to 1-β-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus
172. Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation
173. Human cytomegalovirus IE1 and IE2 proteins block apoptosis
174. Tumor radiosensitivity and apoptosis
175. Pretreatment of normal human fibroblasts and human colon carcinoma cells with MNNG allows chloroethylnitrosurea to produce DNA interstrand crosslinks not observed in cells treated with chloroethylnitrosurea alone
176. Viruses in human cancers
177. Viruses in human tumors - Reminiscences and perspectives